Fengjiao Hu

机构：Sichuan University, Wuhan University, West China Hospital of Sichuan University, Zhongnan Hospital of Wuhan University · ORCID：0000-0002-2235-6652

发表论文 27 篇 · 总被引 823 次 · h-index 17

代表论文

• Fatty Acid Synthase–Suppressor Screening Identifies Sorting Nexin 8 as a Therapeutic Target for NAFLD (2021 · Hepatology · 被引 110)
• Hepatocyte glutathione S-transferase mu 2 prevents non-alcoholic steatohepatitis by suppressing ASK1 signaling (2021 · Journal of Hepatology · 被引 74)
• TMBIM1 is an inhibitor of adipogenesis and its depletion promotes adipocyte hyperplasia and improves obesity-related metabolic disease (2021 · Cell Metabolism · 被引 68)
• FGF4 protects the liver from nonalcoholic fatty liver disease by activating the AMP‐activated protein kinase–Caspase 6 signal axis (2022 · Hepatology · 被引 65)
• Ca 2+ -Dependent NOX5 (NADPH Oxidase 5) Exaggerates Cardiac Hypertrophy Through Reactive Oxygen Species Production (2020 · Hypertension · 被引 63)
• The E3 Ubiquitin Ligase Ring Finger Protein 5 Ameliorates NASH Through Ubiquitin‐Mediated Degradation of 3‐Hydroxy‐3‐Methylglutaryl CoA Reductase Degradation Protein 1 (2021 · Hepatology · 被引 55)